Tuesday, 12 July 2011

Influential Blog Focuses on Neptune

Neptune Technologies & Bioressources
Basic Shares: 48.2 million
Fully diluted: 53.9 million

Neptune Technologies (NTB) was today featured in an influential blog called BioTuesday.

Penned by retired Globe and Mail writer, Leonard Zehr, the well-written article weaves its way through the complex science driving Neptune and its subsidiaires, publicly-traded Acasti Pharma (APO) and NeuroBioPharm, which hasn't opened on public markets yet.

It's a must read for the most sophisticated current investor and, certainly, potential investors.

BioTuesday is a healthcare business and investment news blog published by a New York-based investor relations firm called Kilmer Lucas that specializes in the healthcare sector.